We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
+13.23%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$138B
AUM Growth
+$12.8B
(+10%)
Cap. Flow
-$1.91B
Cap. Flow
% of AUM
-1.38%
Top 10 Holdings %
Top 10 Hldgs %
30.43%
Holding
301
New
8
Increased
70
Reduced
156
Closed
8
Avg Time Held
4.4
years
Top 10 Avg Time Held
4.6
years
Top 20 Avg Time Held
3.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$258M |
| 2 |
BioMarin Pharmaceuticals
BMRN
|
+$88.2M |
| 3 |
Visa
V
|
+$74.2M |
| 4 |
Raymond James Financial
RJF
|
+$72.1M |
| 5 |
LivaNova
LIVN
|
+$70.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$304M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$283M |
| 3 |
Insulet
PODD
|
+$255M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$242M |
| 5 |
Adobe
ADBE
|
+$229M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Healthcare | 26.48% |
| 3 | Industrials | 14.72% |
| 4 | Financials | 10.81% |
| 5 | Consumer Discretionary | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
151
NMI Holdings
NMIH
$3.02B
| $75.6M | 0.05% |
2,279,449
| – | – |
2017 Q4
8 quarters
|
|
152
Ulta Beauty
ULTA
$26B
| $75.4M | 0.05% |
297,900
+2,000
| +0.7% | +$489K |
2017 Q4
8 quarters
|
|
153
Restaurant Brands International
QSR
$25.8B
| $73.8M | 0.05% |
1,156,500
+84,100
| +8% | +$5.63M |
2017 Q4
8 quarters
|
|
154
BioNTech
BNTX
$22.7B
| $72.1M | 0.05% |
+2,128,182
| New | +$47.7M |
2019 Q4
0 quarters
|
|
155
Hilton Worldwide
HLT
$77.2B
| $70.4M | 0.05% |
635,165
-14,100
| -2% | -$1.41M |
2015 Q2
18 quarters
|
|
156
HubSpot
HUBS
$11.9B
| $70M | 0.05% |
441,750
-14,300
| -3% | -$2.19M |
2016 Q1
15 quarters
|
|
157
Axcelis
ACLS
$3.55B
| $69.7M | 0.05% |
2,891,100
-25,700
| -0.9% | -$541K |
2014 Q1
23 quarters
|
|
158
Corteva
CTVA
$8.59B
| $69.2M | 0.05% |
2,341,918
-2,226
| -0.1% | -$58.9K |
2019 Q2
2 quarters
|
|
159
Palo Alto Networks
PANW
$303B
| $62.4M | 0.05% |
1,619,760
+88,800
| +6% | +$3.36M |
2019 Q1
3 quarters
|
|
160
Rockwell Automation
ROK
$46.9B
| $62.4M | 0.05% |
307,955
-350
| -0.1% | -$64.8K |
2013 Q2
26 quarters
|
|
161
Tyson Foods
TSN
$19B
| $60.8M | 0.04% |
667,500
-6,100
| -0.9% | -$525K |
2014 Q4
20 quarters
|
|
|
NUVA
162
DELISTED
NuVasive, Inc.
NUVA
| $60.3M | 0.04% |
780,100
| – | – |
2013 Q2
26 quarters
|
|
|
ARNA
163
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $58.6M | 0.04% |
1,291,000
-75,000
| -5% | -$3.55M |
2018 Q3
5 quarters
|
|
164
NN Inc
NNBR
$327M
| $58.6M | 0.04% |
6,336,400
+20,900
| +0.3% | +$168K |
2014 Q1
23 quarters
|
|
165
Linde
LIN
$227B
| $58.5M | 0.04% |
275,000
-620,500
| -69% | -$125M |
2018 Q4
4 quarters
|
|
166
Charles River Laboratories
CRL
$14.6B
| $58.4M | 0.04% |
382,200
-1,400
| -0.4% | -$194K |
2013 Q2
26 quarters
|
|
167
VF Corp
VFC
$6.68B
| $58.3M | 0.04% |
585,000
| – | – |
2013 Q2
26 quarters
|
|
168
Las Vegas Sands
LVS
$24.8B
| $57.4M | 0.04% |
831,900
| – | – |
2013 Q2
26 quarters
|
|
|
MNTA
169
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $54.2M | 0.04% |
2,749,400
| – | – |
2013 Q2
26 quarters
|
|
|
CALA
170
DELISTED
Calithera Biosciences, Inc
CALA
| $54.2M | 0.04% |
+474,400
| New | +$35.7M |
2019 Q4
0 quarters
|
|
171
Western Digital
WDC
$133B
| $53.8M | 0.04% |
1,120,695
+4,385
| +0.4% | +$183K |
2016 Q2
14 quarters
|
|
172
CSX Corp
CSX
$90.2B
| $53.1M | 0.04% |
2,202,600
| – | – |
2013 Q2
26 quarters
|
|
173
SLB Ltd
SLB
$71.8B
| $51.9M | 0.04% |
1,290,956
+106,200
| +9% | +$3.79M |
2013 Q2
26 quarters
|
|
174
Rhythm Pharmaceuticals
RYTM
$6.06B
| $48.1M | 0.03% |
2,093,691
+1,846,714
| +748% | +$41M |
2019 Q3
1 quarter
|
|
175
DELISTED
Altair Engineering Inc
ALTR
| $48M | 0.03% |
1,336,600
+178,600
| +15% | +$6.03M |
2017 Q4
8 quarters
|
|
Similar funds
Primecap Management's Q4 2019 Portfolio in Review
As of Q4 2019, Primecap Management held 301 positions worth $138B, up 10% from $125B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Primecap Management's Q4 2019 filing shows 8 new, 70 increased, 156 reduced and 8 closed positions. Its largest new stake was BioNTech: 2,128,182 shares worth $72.1M. The largest sale was Alphabet (Google) Class C, an estimated $304M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q4 2019 buy was BioNTech: 2,128,182 shares worth $72.1M.
- Primecap Management added most to Biogen in Q4 2019, an estimated $258M increase.
- Primecap Management's biggest Q4 2019 reduction was Alphabet (Google) Class C, cutting an estimated $304M.
- Primecap Management fully exited Spirit AeroSystems in Q4 2019, selling an estimated $13.5M.
- Primecap Management's ten largest holdings make up 30% of its $138B portfolio in Q4 2019.
- Primecap Management opened 8 new positions and closed 8 in Q4 2019.
- Primecap Management's portfolio value rose 10% quarter-over-quarter to $138B.
Based on Primecap Management's 13F filing for Q4 2019, filed 14 Feb 2020.